{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:38:21Z","timestamp":1771529901770,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T00:00:00Z","timestamp":1489708800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"FEDER and FCT\/MEC","award":["PT2020 UID\/MULTI\/04378\/2013"],"award-info":[{"award-number":["PT2020 UID\/MULTI\/04378\/2013"]}]},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","award":["NORTE-01-0145-FEDER-000011"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000011"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["(IF\/00293\/2015)"],"award-info":[{"award-number":["(IF\/00293\/2015)"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Facepe","doi-asserted-by":"crossref","award":["1316-4.03\/12"],"award-info":[{"award-number":["1316-4.03\/12"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["482954\/2013-2"],"award-info":[{"award-number":["482954\/2013-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s11095-017-2136-0","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T14:58:59Z","timestamp":1489762739000},"page":"1204-1216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Multiple Lipid Nanoparticles (MLN), a New Generation of Lipid Nanoparticles for Drug Delivery Systems: Lamivudine-MLN Experimental Design"],"prefix":"10.1007","volume":"34","author":[{"given":"Suellen M. T.","family":"Cavalcanti","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-3710","authenticated-orcid":false,"given":"Cl\u00e1udia","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Sofia A. C.","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 L.","family":"Soares-Sobrinho","sequence":"additional","affiliation":[]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"issue":"5","key":"2136_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1517\/17425247.2012.673278","volume":"9","author":"L Battaglia","year":"2012","unstructured":"Battaglia L, Gallarate M. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv. 2012;9(5):497\u2013508.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"2136_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1208\/s12249-010-9563-0","volume":"12","author":"S Das","year":"2011","unstructured":"Das S, Chaudhury A, PharmSciTech A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech. 2011;12(1):62\u201376.","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"2136_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"J Pardeike","year":"2009","unstructured":"Pardeike J, Hommoss A, M\u00fcller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1\u20132):170\u201384.","journal-title":"Int J Pharm"},{"key":"2136_CR4","doi-asserted-by":"publisher","unstructured":"Severino P, Andreani T, Macedo AS, Fangueiro JF, Santana MHA, Silva AM, Souto EB. Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J Drug Deliv. 2012;2012:10\u20130.","DOI":"10.1155\/2012\/750891"},{"key":"2136_CR5","unstructured":"Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. In.: Google Patents. 1993."},{"key":"2136_CR6","unstructured":"Lucks S, M\u00fcller R. Medication vehicles made of solid lipid particles (solid lipid nanospheres - sln). In.: Google Patents. 1996."},{"key":"2136_CR7","first-page":"2733","volume":"8","author":"A Ali Khan","year":"2013","unstructured":"Ali Khan A, Mudassir J, Mohtar N, Darwis Y. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomedicine. 2013;8:2733\u201344.","journal-title":"Int J Nanomedicine"},{"issue":"12","key":"2136_CR8","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1080\/03639040802130061","volume":"34","author":"M Muchow","year":"2008","unstructured":"Muchow M, Maincent P, M\u00fcller RH. Lipid nanoparticles with a solid matrix (SLN\u00ae, NLC\u00ae, LDC\u00ae) for oral drug delivery. Drug Dev Ind Pharm. 2008;34(12):1394\u2013405.","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"2136_CR9","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/ejlt.201400398","volume":"117","author":"G Zhao","year":"2015","unstructured":"Zhao G, Hu C, Sun R, Ni S, Li Q, Xia Q. Development of novel composite antioxidant multiple lipid particles from combination of W\/O\/W multiple emulsions and solid lipid nanoparticles. Eur J Lipid Sci Technol. 2015;117(7):1056\u201365.","journal-title":"Eur J Lipid Sci Technol"},{"issue":"3","key":"2136_CR10","first-page":"16","volume":"3","author":"SP Chaturvedi","year":"2012","unstructured":"Chaturvedi SP, Kumar V. Production techniques of lipid nanoparticles: a review. Res J Pharm, Biol Chem Sci. 2012;3(3):16.","journal-title":"Res J Pharm, Biol Chem Sci"},{"key":"2136_CR11","unstructured":"ICH. Quality risk management Q9. In.: International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use; 2005."},{"key":"2136_CR12","unstructured":"ICH. Pharmaceutical development - Q8(R2). In.: International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use; 2009."},{"key":"2136_CR13","unstructured":"Ben\u00edcio de Barros Neto Roy Edward Bruns ISS, Bookman. Como fazer experimentos: Bookman; 2010."},{"key":"2136_CR14","unstructured":"ICH. Pharmaceutical quality system - Q10. In. \nhttp:\/\/www.fda.gov\/downloads\/Drugs\/...\/Guidances\/ucm073517.pdf:\n\n International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use; 2009."},{"key":"2136_CR15","unstructured":"Maria Isabel Rodrigues AFL, C\u00e1rita. Planejamento de Experimentos e Otimiza\u00e7\u00e3o de Precessos: C\u00e1rita; 2014."},{"issue":"1","key":"2136_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jpba.2008.10.002","volume":"49","author":"G Bedse","year":"2009","unstructured":"Bedse G, Kumar V, Singh S. Study of forced decomposition behavior of lamivudine using LC, LC\u2013MS\/TOF and MSn. J Pharm Biomed Anal. 2009;49(1):55\u201363.","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"2136_CR17","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/jps.22449","volume":"100","author":"S Strauch","year":"2011","unstructured":"Strauch S, Jantratid E, Dressman JB, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM. Biowaiver monographs for immediate release solid oral dosage forms: lamivudine. J Pharm Sci. 2011;100(6):2054\u201363.","journal-title":"J Pharm Sci"},{"issue":"2","key":"2136_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","volume":"58","author":"M Lindenberg","year":"2004","unstructured":"Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58(2):265\u201378.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"2136_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1517\/17425247.3.5.613","volume":"3","author":"TK Vyas","year":"2006","unstructured":"Vyas TK, Shah L, Amiji MM. Nanoparticulate drug carriers for delivery of HIV\/AIDS therapy to viral reservoir sites. Expert Opin Drug Deliv. 2006;3(5):613\u201328.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1\u20132","key":"2136_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijpharm.2015.07.013","volume":"492","author":"M Ferreira","year":"2015","unstructured":"Ferreira M, Chaves LL, Lima SAC, Reis S. Optimization of nanostructured lipid carriers loaded with methotrexate: a tool for inflammatory and cancer therapy. Int J Pharm. 2015;492(1\u20132):65\u201372.","journal-title":"Int J Pharm"},{"key":"2136_CR21","first-page":"311","volume":"1","author":"WC Griffin","year":"1949","unstructured":"Griffin WC. Classification of surface-active agents by \u201cHLB\u201d. J Soc Cosmet Chem. 1949;1:311\u201326.","journal-title":"J Soc Cosmet Chem"},{"key":"2136_CR22","first-page":"249","volume":"5","author":"WC Griffin","year":"1954","unstructured":"Griffin WC. Calculation of HLB values of non-ionic surfactants. J Soc Cosmet Chem. 1954;5:249\u201356.","journal-title":"J Soc Cosmet Chem"},{"issue":"1\u20132","key":"2136_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijpharm.2012.09.054","volume":"439","author":"S Martins","year":"2012","unstructured":"Martins S, Tho I, Reimold I, Fricker G, Souto E, Ferreira D, Brandl M. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Int J Pharm. 2012;439(1\u20132):49\u201362.","journal-title":"Int J Pharm"},{"issue":"2","key":"2136_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0378-5173(01)00882-1","volume":"231","author":"N Sch\u00f6ler","year":"2002","unstructured":"Sch\u00f6ler N, Hahn H, M\u00fcller RH, Liesenfeld O. Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages. Int J Pharm. 2002;231(2):167\u201376.","journal-title":"Int J Pharm"},{"key":"2136_CR25","unstructured":"Block ID. Particle sizing by 3D cross-correlation DLS in highly scattering samples. In. \nhttp:\/\/www.lsinstruments.ch\/__\/frontend\/handler\/document.php?id=265&type=42:\n\n LS Instruments; 2010."},{"issue":"1\u20132","key":"2136_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0378-5173(00)00623-2","volume":"214","author":"A Lippacher","year":"2001","unstructured":"Lippacher A, M\u00fcller RH, M\u00e4der K. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. Int J Pharm. 2001;214(1\u20132):9\u201312.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"2136_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijpharm.2011.05.008","volume":"414","author":"K Mitri","year":"2011","unstructured":"Mitri K, Shegokar R, Gohla S, Anselmi C, M\u00fcller RH. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int J Pharm. 2011;414(1\u20132):267\u201375.","journal-title":"Int J Pharm"},{"issue":"1","key":"2136_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0168-3659(00)00364-3","volume":"71","author":"F S-s","year":"2001","unstructured":"S-s F, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol\u00ae) from nanospheres of biodegradable polymers. J Control Release. 2001;71(1):53\u201369.","journal-title":"J Control Release"},{"issue":"3","key":"2136_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0168-3659(02)00056-1","volume":"81","author":"SA Wissing","year":"2002","unstructured":"Wissing SA, Muller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release. 2002;81(3):225\u201333.","journal-title":"J Control Release"},{"key":"2136_CR30","doi-asserted-by":"publisher","unstructured":"Mishra PR, Shaal LA, M\u00fcller RH, Keck CM. Production and characterization of Hesperetin nanosuspensions for dermal delivery. Int J Pharm 2009;371(1\u20132):182\u2013189.","DOI":"10.1016\/j.ijpharm.2008.12.030"},{"issue":"1","key":"2136_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejpb.2004.02.015","volume":"58","author":"EB Souto","year":"2004","unstructured":"Souto EB, Wissing SA, Barbosa CM, M\u00fcller RH. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur J Pharm Biopharm. 2004;58(1):83\u201390.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"2136_CR32","first-page":"80","volume":"2","author":"P Ekambaram","year":"2012","unstructured":"Ekambaram P, Satahali AAH, Priyanka K. Solid lipid nanoparticles: review. Scientific Reviews Chemical Communications. 2012;2(1):80\u2013102.","journal-title":"Scientific Reviews Chemical Communications"},{"key":"2136_CR33","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.2147\/DDDT.S109589","volume":"10","author":"I Frias","year":"2016","unstructured":"Frias I, Neves AR, Pinheiro M, Reis S. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation. Drug Des Devel Ther. 2016;10:3519\u201328.","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"2136_CR34","first-page":"743","volume":"2","author":"B Sarmento","year":"2007","unstructured":"Sarmento B, Martins S, Ferreira D, Souto EB. Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomedicine. 2007;2(4):743\u20139.","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"2136_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4103\/0250-474X.108419","volume":"74","author":"M Shah","year":"2012","unstructured":"Shah M, Agrawal YK, Garala K, Ramkishan A. Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride. Indian J Pharm Sci. 2012;74(5):434\u201342.","journal-title":"Indian J Pharm Sci"},{"issue":"5","key":"2136_CR36","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1248\/cpb.58.650","volume":"58","author":"S Singh","year":"2010","unstructured":"Singh S, Dobhal AK, Jain A, Pandit JK, Chakraborty S. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine. Chem Pharm Bull. 2010;58(5):650\u20135.","journal-title":"Chem Pharm Bull"},{"key":"2136_CR37","unstructured":"Muller RH, Becker R, Kruss B, Peters K. Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution. In.: Google Patents; 1999."},{"key":"2136_CR38","unstructured":"Zur Muhlen A, Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie. 1998;53(8)"},{"issue":"2\u20133","key":"2136_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2\u20133):165\u201396.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2136_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0939-6411(03)00020-1","volume":"55","author":"A Dubes","year":"2003","unstructured":"Dubes A, Parrot-Lopez H, Abdelwahed W, Degobert G, Fessi H, Shahgaldian P, Coleman AW. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm. 2003;55(3):279\u201382.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3\u20134","key":"2136_CR41","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ejps.2010.08.004","volume":"41","author":"Q Li","year":"2010","unstructured":"Li Q, Du Y-Z, Yuan H, Zhang X-G, Miao J, Cui F-D, Hu F-Q. Synthesis of lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system. Eur J Pharm Sci. 2010;41(3\u20134):498\u2013507.","journal-title":"Eur J Pharm Sci"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-017-2136-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-017-2136-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-017-2136-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T18:15:52Z","timestamp":1589739352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-017-2136-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["2136"],"URL":"https:\/\/doi.org\/10.1007\/s11095-017-2136-0","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,17]]}}}